Normal view MARC view ISBD view

Clinical evaluation of three toothbrush models tested by schoolchildren. [electronic resource]

By:

Stroski, M L

Contributor(s):

Producer: 20110829Description: 149-54 p. digitalISSN:

1601-5037

Subject(s):

Online resources:

Available from publisher's website

In: International journal of dental hygiene vol. 9

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial

There are no comments on this title.

to post a comment.

Back to results

581 Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI).
by Rider, Lisa G
582 Interventions for dysphagia in long-term, progressive muscle disease.
by Jones, Katherine
583 Psychometric validation of a patient-reported measure of physical functioning in sporadic inclusion body myositis.
by Williams, Valerie
584 A cross-sectional study of hand function in inclusion body myositis: Implications for functional rating scale.
by Lin, Ava Yun
585 Inclusion body myositis associated with celiac sprue and idiopathic thrombocytopenic purpura.
by Williams, Sandra F
586 Various types of hereditary inclusion body myopathies map to chromosome 9p1-q1.
by Argov, Z
587 Treatment of inclusion body myositis: is low-dose intravenous immunoglobulin the solution?
by Recher, Mike
588 Interplay between inflammation and degeneration: using inclusion body myositis to study "neuroinflammation".
by Dalakas, Marinos C
589 Pediatric macrophagic myofasciitis associated with motor delay.
by Gruis, K L
590 T cell receptor profiling in muscle and blood lymphocytes in sporadic inclusion body myositis.
by Salajegheh, M
591 Biologics in the treatment of primary inflammatory myositis.
by Wendling, Daniel
592 Autoantibodies produced at the site of tissue damage provide evidence of humoral autoimmunity in inclusion body myositis.
by Ray, Arundhati
593 Electromyographs of the flexor digitorum profundus muscle are useful for the diagnosis of inclusion body myositis.
by Hokkoku, Keiichi
594 Frequency and circumstances of falls in people with inclusion body myositis: a questionnaire survey to explore falls management and physiotherapy provision.
by Hiscock, A
595 Automatic decomposition electromyography in idiopathic inflammatory myopathies.
by Jongen, P J
596 Sporadic inclusion body myositis: counts of different types of abnormal fibers.
by Pruitt, J N
597 Role of cytokines and chemokines in idiopathic inflammatory myopathies.
by De Paepe, Boel
598 Valosin-containing protein disease: inclusion body myopathy with Paget's disease of the bone and fronto-temporal dementia.
by Weihl, Conrad C
599 Potential therapeutic targets for idiopathic inflammatory myopathies.
by De Bleecker, Jan L
600 Copper reduces Aβ oligomeric species and ameliorates neuromuscular synaptic defects in a C. elegans model of inclusion body myositis.
by Rebolledo, Daniela L